Tyrosinemia

Tyrosinemia is a rare genetic condition where the body can't properly break down the amino acid tyrosine. This leads to too much tyrosine building up in the blood and urine. It's caused by a missing enzyme that helps process tyrosine. There are different types, each with its own specific symptoms and cause.

Condition

What people with Tyrosinemia report

Every report comes from a Lived member, sent anonymously.

Have you tried Low-Protein Diet for Tyrosinemia?

NameHow it went

About Tyrosinemia

What It Is

Tyrosinemia is a group of rare inherited disorders in which the body cannot fully break down tyrosine, one of the amino acids that make up the protein in food. Each type involves a missing or weak liver enzyme, so tyrosine or the substances made from it build up to harmful levels. There are three types, and they differ a great deal in which parts of the body they affect and how serious they are. Type 1, also called hepatorenal tyrosinemia, is the most common and the most serious. Without treatment it usually appears in the first months of life with poor weight gain, vomiting, diarrhea, jaundice (yellowing of the skin and eyes) and easy bleeding such as nosebleeds. It can lead to liver failure, kidney damage, rickets (soft, weak bones) and liver cancer. Some untreated children have repeated nerve crises lasting days, with severe pain in the legs or belly, changes in alertness and sometimes breathing failure. Newborn screening can now find type 1 within days of birth, so treatment can start before these problems develop. Type 2, also called Richner-Hanhart syndrome, mainly affects the eyes and skin: red, painful, watery eyes that are very sensitive to light, and thick, painful skin on the palms and soles. About half of people with type 2 have some degree of intellectual disability. Type 3 is the rarest, with only a small number of cases described, mostly involving intellectual disability, seizures or episodes of unsteadiness. Types 2 and 3 do not damage the liver.

Causes & Risk Factors

All three types are genetic and present from birth. They are inherited in an autosomal recessive pattern, which means a child is affected only when they inherit a non-working copy of the same gene from each parent. Parents who carry one copy are usually healthy and often learn they are carriers only when a child is diagnosed. When both parents are carriers, each pregnancy has a 1 in 4 chance of an affected child, a 1 in 2 chance of a healthy carrier, and a 1 in 4 chance of a child who is neither. Each type comes from a different gene, and each gene controls a different step in breaking down tyrosine. Type 1 affects about 1 in 100,000 people worldwide but is far more common in some communities, particularly in Quebec, Canada. Type 2 affects fewer than 1 in 250,000 people. In someone who already has type 1, certain situations can push the condition out of control: going a long time without food, illnesses such as infections or fevers that make the body break down its own protein, and eating much more or much less protein than the treatment plan allows.

How It's Diagnosed

Type 1 is most often found through newborn screening, the heel-prick blood test done shortly after birth. The screen looks for succinylacetone, a toxic substance that builds up only in type 1 and is a more dependable marker than tyrosine itself. A positive screen is a signal for urgent follow-up, not a diagnosis. Confirmation comes from finding raised succinylacetone in the baby's blood and urine, or changes in both copies of the type 1 gene on genetic testing. Types 2 and 3 are usually diagnosed after symptoms appear. Very high blood tyrosine without succinylacetone points to one of them, and genetic testing tells them apart. Type 2 is sometimes first suspected by an eye doctor or skin specialist, because its eye inflammation can look like a viral eye infection that fails to improve with antiviral treatment. A raised tyrosine level on its own does not always mean inherited tyrosinemia. Temporary high tyrosine is common in newborns, especially those born early, and settles without being a genetic disease. Because tyrosinemia runs in families, brothers and sisters of an affected child should be tested even if they seem well, and parents who know their gene changes can have testing in a future pregnancy.

Treatment Options

Type 1 is treated with two things that work together: a daily medicine called nitisinone and a protein-restricted diet. Nitisinone (sold as Orfadin and Nityr) blocks an earlier step in tyrosine breakdown, which stops the toxic substances that damage the liver, kidneys and nerves from forming. When started early alongside the diet, it has raised survival above 90% and allows normal growth, better liver function, prevention of cirrhosis (liver scarring), correction of the kidney problems and healing of rickets. Treatment is lifelong, and taking it consistently is what prevents nerve crises and liver damage from returning. Because nitisinone stops tyrosine from being broken down further, tyrosine levels in the blood rise. The diet keeps them in a safe range by limiting tyrosine and phenylalanine, a closely related amino acid. In practice this means carefully measured amounts of natural protein, with special medical foods supplying the rest, planned with a metabolic dietitian. If tyrosine climbs too high, it can cause painful eye inflammation, light sensitivity and thick, painful skin on the palms and soles, and very high levels have been linked to effects on learning and development. The answer is to adjust the diet, not to lower the nitisinone dose, which should only be changed by the specialist team. People taking nitisinone have an eye examination before starting and regularly afterward, along with routine blood counts. A liver transplant is reserved for children whose severe liver failure does not respond to nitisinone, or who develop liver cancer. Types 2 and 3 have no specific medicine. Treatment is the same kind of tyrosine- and phenylalanine-restricted diet. In type 2, the eye and skin problems typically clear on the diet, but learning problems that have already developed tend to remain, which is why early diagnosis matters. Experience with type 3 comes from a small number of children, and how much the diet helps is less certain.

What to Expect

Tyrosinemia is lifelong, but the outlook for type 1 has changed dramatically. Without treatment, most children with type 1 did not survive past age 10; with early diagnosis and treatment, people now live into adulthood, and most babies found through newborn screening can stay free of symptoms. Daily life centers on the medicine and the diet: regular meals, measured protein and medical foods, and a plan that changes as a child grows. Follow-up is frequent, especially in the first years. It includes blood and urine tests to check tyrosine, succinylacetone and nitisinone levels, liver tests, and liver imaging about once a year to watch for liver cancer. Kidney function, bone health, development and vision are checked as well, and learning assessments are recommended before a child starts school. Teenagers gradually take over their own diet and medicine and move to adult metabolic care, and adults with type 1 who are planning a pregnancy should discuss it with their team, since experience with nitisinone in pregnancy is limited. For type 2, life is usually shaped by the diet and by eye and skin follow-up, with developmental support when it is needed. Because so few people have type 3, its long-term course is not well known.

When to Seek Help

Babies with a positive newborn screen, and children or adults who develop unexplained painful light-sensitive eyes together with thick, painful skin on the palms or soles, should be seen by a specialist in inherited metabolic disorders without delay. For someone with type 1, contact the metabolic team promptly during any illness with vomiting, fever or poor feeding, if doses of nitisinone cannot be taken or kept down, or before any surgery or procedure that requires fasting, and follow the written emergency plan the team provides. Anyone taking nitisinone who develops eye pain, redness or new sensitivity to light should also contact the team promptly, since it can mean tyrosine is too high. Severe pain in the legs or belly, confusion or reduced alertness, new weakness, or trouble breathing in someone with type 1 can signal a nerve crisis and needs emergency care; bring the emergency letter from the metabolic team.

Questions to Ask Your Doctor

  1. 1.Which type of tyrosinemia is this, and what does that mean for the liver, eyes, skin and development?
  2. 2.What tyrosine and phenylalanine targets are we aiming for, and how will the diet change as my child grows?
  3. 3.What should we do on sick days, and what goes in our written emergency plan?
  4. 4.How often will we need blood tests, eye exams and liver scans, and what is each one looking for?
  5. 5.Should other family members have genetic testing, and what are the options for a future pregnancy?

Last reviewed • Oct 2026

Educational content, not medical advice.